E

Endeavor Biomedicines

22 employees

Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical
Health Care

Date founded

2018

Funding rounds raised

Total raised

$101M

from 9 investors over 9 rounds

E

Endeavor Biomedicines raised $101M on February 7, 2022

Investors: Omega Funds, Revelation Partners, Longitude Capital, T. Rowe Price, Avidity Partners, Perceptive Advisors and Tekla Capital Management

E

Endeavor Biomedicines raised $62M on January 7, 2021

Investors: Omega Funds and Longitude Capital

FAQ